Pharmafile Logo

12 Connected Health

Seizing the opportunities in a new era of care

In recent decades, emerging technologies have repeatedly forced smart companies to answer the question: what’s new here and what’s our strategy now? It happened in the mid-90s as the Internet took off, in the mid-2000s as online video and social media went mainstream, and then again with the rise of smartphones and mobile devices in 2008.

Today, smart pharma companies should be asking that same question about another major development: Connected Health. This combination of technology, circumstance, and mindset has the potential to transform a sector of the economy worth $2.8 trillion1 in the United States alone. The transformation will certainly involve established incumbents in the healthcare market, especially pharma companies, device and equipment manufacturers, healthcare providers, and insurers. It will also draw new entrants who will be eager to create new services and identify ways to reduce costs. Having little or no experience in healthcare may well give these new entrants an advantage—they will see the market with fresh eyes, allowing them to come up with innovative ways to create value.

This content was provided by Havas Lynx

Documents for download:

Company Details

 Latest Content from  Havas Lynx 

Healing the Healers

Because if we do not heal the healers, who is going to heal us?

THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide

The campaign encourages people who use drugs to do something remarkable – save a life

Andi Goes – the children’s book that helps detect early signs of dyslexia

Havas Lynx Group have launched a children’s book aimed at raising awareness and detecting early signs of dyslexia. Helping to make sure that parents have the support they need whilst…

Neurofibromatosis: a condition that’s hard to say, but even harder to live with

The Childhood Tumour Trust and Havas Lynx Group have launched a campaign to raise awareness and funds for people living with a rare genetic condition, neurofibromatosis 1 (NF1).

Havas Health & You Launches Behind the Mask, a Global Research Initiative to Document Health Experiences During the COVID-19 Pandemic and Beyond

Havas Health & You (HH&Y) have launched the details of a long-term global research project, Behind the Mask, a longitudinal, multi-armed study which focuses on documenting the ongoing evolution of…

Media Means Business

Creating meaningful media experiences in pharma

Havas Lynx Group elevates Jon Chapman and Paul Kinsella to CCOs

Havas Lynx Group announces the promotion of Jon Chapman and Paul Kinsella from Executive Creative Directors (ECD) to Chief Creative Officers (CCO) for Havas Lynx Group.